Finance

Lists
Why is ATHE down ४.४६%?
Dive Deeper
ATHE:NASDAQ
Alterity Therapeutics Ltd
US$ ३.४९
-४.४६%
(-०.१६) 1D
अक्टोबर १, १४:५०:१४ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ATHE...
Open
US$ ३.५३
High
US$ ३.५७
Low
US$ ३.३८
Mkt. cap
६.१५ करोड
Avg. vol.
१८.२७ हजार
Volume
२१.८५ हजार
52-wk high
US$ ५.८९
52-wk low
US$ २.६९
EPS
-US$ ०.९३
Beta
०.२९
Shares outstanding
१.९१ करोड
No. of employees
११
Open
US$ ३.५३
High
US$ ३.५७
Low
US$ ३.३८
Mkt. cap
६.१५ करोड
Avg. vol.
१८.२७ हजार
Volume
२१.८५ हजार
52-wk high
US$ ५.८९
52-wk low
US$ २.६९
EPS
-US$ ०.९३
Beta
०.२९
Shares outstanding
१.९१ करोड
No. of employees
११
News stories
From web sources and news partners
About Alterity Therapeutics Ltd
CEO-
Employees११
Founded१९९७
Headquartersमेलबर्न, भिक्टोरिया, अष्ट्रेलिया
Sector-
Websitealteritytherapeutics.com
Analyst ratings
Based on 3 analysts giving stock ratings to ATHE in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ATHE in the last 3 months.
Highest
Current US$ ३.४९
US$ १६.०० (+३५८.८३%)
Average
US$ १२.६७ (+२६३.३४%)
Lowest
US$ १०.०० (+१८६.७७%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Flaten
Lake Street
Buy
Maintained
US$ १०.००
+१८६.८%
09/28/2026
Debanjana Chatterjee
JonesTrading
Buy
Maintained
US$ १६.००
+३५८.८%
08/28/2026
Adam Vogel
Craig-Hallum
Buy
Initiated
US$ १२.००
+२४४.१%
08/11/2026
Caroline Palomeque
Ladenburg Thalmann & Co.
Buy
Initiated
US$ १०.००
+१८६.८%
06/16/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Initiated
US$ १०.००
+१८६.८%
06/16/2026
Jason McCarthy
Maxim Group
Buy
Reiterated
US$ १२.००
+२४४.१%
06/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१४.०२ लाख
१४.०२ लाख
४.०३ लाख
४.०३ लाख
Cost of goods sold
४९.४३ हजार
४९.४३ हजार
८१.९६ हजार
८१.९६ हजार
Cost of revenue
४९.४३ हजार
४९.४३ हजार
८१.९६ हजार
८१.९६ हजार
Research and development expenses
३९.२१ लाख
३९.२१ लाख
४८.९४ लाख
४८.९४ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२५.५८ लाख
२५.५८ लाख
२७.०६ लाख
२७.०६ लाख
Operating expense
६५.७५ लाख
६५.७५ लाख
७६.४६ लाख
७६.४६ लाख
Total operating expenses
६६.२४ लाख
६६.२४ लाख
७७.२८ लाख
७७.२८ लाख
Operating income
-५२.२३ लाख
-५२.२३ लाख
-७३.२४ लाख
-७३.२४ लाख
Other non operating income
-
-
-
-
EBT including unusual items
-४७.७७ लाख
-४७.७७ लाख
-६८.६७ लाख
-६८.६७ लाख
EBT excluding unusual items
-४७.७७ लाख
-४७.७७ लाख
-६८.६७ लाख
-६८.६७ लाख
Income tax expense
३०.७८ हजार
३०.७८ हजार
२५.९७ हजार
२५.९७ हजार
Effective tax rate
-०.६४%
-०.६४%
-०.३८%
-०.३८%
Other operating expenses
९५.६७ हजार
९५.६७ हजार
४६.२६ हजार
४६.२६ हजार
Net income
-४८.०८ लाख
-४८.०८ लाख
-६८.९३ लाख
-६८.९३ लाख
Net profit margin
-३४३.००%
-३४३.००%
-१,७०९.०६%
-१,७०९.०६%
Earnings per share
-
-
-
-
Interest and investment income
४.५५ लाख
४.५५ लाख
४.०३ लाख
४.०३ लाख
Interest expense
-
-
-
-
Net interest expenses
४.५५ लाख
४.५५ लाख
४.०३ लाख
४.०३ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-५२.२२ लाख
-५२.२२ लाख
-७३.२४ लाख
-७३.२४ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू